Perry, Vloedman & Brady Blog LA Times Editorial: U.S. should be vigilant about counterfeit medicines

In a recent editorial, the Los Angeles Times writes, "In the United States, the problem of counterfeit drugs is still relative rare, but growing. In February, 2012, a counterfeit version of the cancer drug Avastin that contained of the active ingredients was purchased online by various medical groups that were ignorant of the fakery."